Saturday, April 04, 2026
In Detail Full day, Saturday, April 04, 2026, Timezone: America/Chicago
Common metabolic enzyme could predict cancer immunotherapy benefits—and help more patients respond
medicalxpress - Immunotherapies have transformed cancer treatment by helping the immune system recognize and attack tumors. They work for only about 20% of patients, though, and doctors still struggle to predict who will benefit.
AI Summary: New research identifies a common metabolic enzyme as a potential biomarker predicting benefit from cancer immunotherapy, and investigators propose that controlling intracellular metabolite routing could enhance responses. Together, these findings suggest metabolic pathways are both useful predictors and actionable targets to convert non‑responders into responders.
- Metabolic signals predict and boost immunotherapy responses (5)
- Other related research and expert commentary (8)
- Scaling CAR‑T: access, effects, and biomarker collaborations (3)
- Unmasking tumors: epigenetic and immune reprogramming strategies (4)
- All Other Stories
Metabolic signals predict and boost immunotherapy responses
Other related research and expert commentary
Scaling CAR‑T: access, effects, and biomarker collaborations
Unmasking tumors: epigenetic and immune reprogramming strategies
All Other Stories
Rabi Hanna: First-in-Human CRISPR/Cas12a Therapy in Sickle Cell Disease
oncodaily - Rabi Hanna, Pediatric Blood and Marrow Transplant Program Director, and Chairman at the Department of Pediatric Hematology-Oncology and BMT at Cleveland Clinic, shared a post on LinkedIn: “I am excited […]
AI Summary: A first‑in‑human CRISPR/Cas12a therapy for sickle cell disease has treated initial patients, building on preclinical gene‑editing successes that reversed severe disease in models. The advance underscores rapid translation from lab to clinic and renews hope for durable cures—while reminding everyone that the safety and long‑term durability questions remain firmly on the table.
Uveal Melanoma: ESMO–EURACAN Clinical Practice Guideline
esmo - This ESMO–EURACAN CPG provides key recommendations for the diagnosis, staging, treatment and follow-up for uveal melanoma. It includes percutaneous hepatic perfusion and tebentafusp as treatment options for metastatic disease, reflecting emerging evidence…
AI Summary: ESMO–EURACAN released a comprehensive clinical practice guideline for uveal melanoma covering diagnosis, staging, surveillance and systemic management. The guidance clarifies best practices for multidisciplinary care, risk stratification and therapeutic sequencing, aiming to standardize treatment and follow‑up for a rare but high‑risk ocular tumour.
CHS sells 180-bed hospital for $459M: 6 things to know
Alan Condon / beckershospitalreview - Franklin, Tenn.-based Community Health Systems on April 1 sold Crestwood Medical Center — a 180-bed hospital in Huntsville, Ala. — to Huntsville Hospital Health System for $459 million. Six things to know: 1. The deal includes all of the assets tied to th…
AI Summary: Community Health Systems has finalized the sale of a 180‑bed Alabama hospital for $459 million, concluding a transaction that reshuffles local care ownership and may prompt operational changes. The closing marks a notable consolidation step in regional hospital markets and raises questions about continuity and access as the new owner assumes control.
Bowelbabe Fund celebrates raising £20m by announcing the Bowelbabe Vaccine
Sophie Wedekind / cancerresearchuk - The Bowelbabe Fund has raised more that £20 million and has announced the next wave of funded projects, including the Bowelbabe Vaccine.The post Bowelbabe Fund celebrates raising £20m by announcing the Bowelbabe Vaccine appeared first on Cancer Research U…
AI Summary: The Bowelbabe Fund celebrated a £20 million fundraising milestone and unveiled plans for a Bowelbabe Vaccine initiative, drawing high‑profile support. Organizers framed the cash infusion as a catalyst for prevention and research efforts, while public endorsements highlighted momentum — and the fundraising thermometer that finally stopped making them blush.
Targeted, High-dose Radiation May Improve Treatment for ‘Supermassive’ Bile Duct Tumors
Kathleen Medora / aacr - Patients with very large intrahepatic cholangiocarcinoma experienced improved outcomes when targeted, high-dose radiation was added to chemotherapy PHILADELPHIA – Patients with supermassive intrahepatic cholangiocarcinoma (ICC) benefited from ablative rad…
AI Summary: New clinical reports indicate that targeted high‑dose radiation can improve outcomes for very large “supermassive” bile duct tumors, offering better local control and symptom relief than conventional approaches. Early data suggest this intensity‑modulated strategy may expand options for otherwise difficult‑to‑treat cases, though longer follow‑up is needed to confirm survival benefits.
Artemis II officially leaves Earth's orbit on the way to the moon
livescience - With a successful translunar injection burn, NASA's Artemis II mission stopped circling Earth and began the first crewed journey toward the moon since the Apollo era.
AI Summary: NASA’s Artemis II mission has lifted off and cleared Earth’s orbit, sending a diverse crew toward lunar proximity on a high-profile test flight. The launch marked a milestone in human space exploration with live crew messaging, extensive imagery and final mission preparations now shifting to in‑flight systems checks — cue the world watching nervously and proudly.
- Countdown and launch: final checks, liftoff and eyewitness reaction (5)
- Lunar flyby updates: images, science, communication and a heat-shield concern (7)
- Other coverage: culture, families, and broader science context (4)
- Records shattered: farthest, fastest human spaceflight milestones (4)
- All Other Stories
Countdown and launch: final checks, liftoff and eyewitness reaction
Lunar flyby updates: images, science, communication and a heat-shield concern
Other coverage: culture, families, and broader science context
Records shattered: farthest, fastest human spaceflight milestones
All Other Stories
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Digital Health, Pediatric Oncology, Corporate Takeover, Diagnostics and look for the RSS link.
StackHealth Time Machine
More StackHealth